Endogenous biosynthesis of prostaglandin I2 and thromboxane A2 by isolated rat dental pulp.
D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis; D000818:Animals; D003782:Dental Pulp / Q000187:drug effects / Q000378:metabolism*; D015237:Dinoprost; D015232:Dinoprostone; D011464:Epoprostenol / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008689:Methacrylates / Q000494:pharmacology; D011458:Prostaglandins E / Q000096:biosynthesis; D011460:Prostaglandins F / Q000096:biosynthesis; D051381:Rats; D013928:Thromboxane A2 / Q000096:biosynthesis*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D013931:Thromboxanes / Q000096:biosynthesis*; D014191:Tranylcypromine / Q000494:pharmacology
D008689:Methacrylates; D011458:Prostaglandins E; D011460:Prostaglandins F; D013931:Thromboxanes; D014191:Tranylcypromine; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D011464:Epoprostenol; D013930:Thromboxane-A Synthase; D015232:Dinoprostone; C034364:ozagrel; D007213:Indomethacin